Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 21:42:15 GMT 2025
by
admin
on
Mon Mar 31 21:42:15 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG2|LAMDA |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
0Z70DT5PRX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9679
Created by
admin on Mon Mar 31 21:42:15 GMT 2025 , Edited by admin on Mon Mar 31 21:42:15 GMT 2025
|
PRIMARY | |||
|
DB12363
Created by
admin on Mon Mar 31 21:42:15 GMT 2025 , Edited by admin on Mon Mar 31 21:42:15 GMT 2025
|
PRIMARY | |||
|
1204390-13-5
Created by
admin on Mon Mar 31 21:42:15 GMT 2025 , Edited by admin on Mon Mar 31 21:42:15 GMT 2025
|
PRIMARY | |||
|
C82683
Created by
admin on Mon Mar 31 21:42:15 GMT 2025 , Edited by admin on Mon Mar 31 21:42:15 GMT 2025
|
PRIMARY | |||
|
ZZ-18
Created by
admin on Mon Mar 31 21:42:15 GMT 2025 , Edited by admin on Mon Mar 31 21:42:15 GMT 2025
|
PRIMARY | |||
|
Dusigitumab
Created by
admin on Mon Mar 31 21:42:15 GMT 2025 , Edited by admin on Mon Mar 31 21:42:15 GMT 2025
|
PRIMARY | |||
|
SUB128932
Created by
admin on Mon Mar 31 21:42:15 GMT 2025 , Edited by admin on Mon Mar 31 21:42:15 GMT 2025
|
PRIMARY | |||
|
0Z70DT5PRX
Created by
admin on Mon Mar 31 21:42:15 GMT 2025 , Edited by admin on Mon Mar 31 21:42:15 GMT 2025
|
PRIMARY | |||
|
CHEMBL2109355
Created by
admin on Mon Mar 31 21:42:15 GMT 2025 , Edited by admin on Mon Mar 31 21:42:15 GMT 2025
|
PRIMARY | |||
|
100000155088
Created by
admin on Mon Mar 31 21:42:15 GMT 2025 , Edited by admin on Mon Mar 31 21:42:15 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_147 | 1_203 |
| 1_260 | 1_320 |
| 1_366 | 1_424 |
| 2_22 | 2_96 |
| 2_147 | 2_203 |
| 2_260 | 2_320 |
| 2_366 | 2_424 |
| 3_22 | 3_89 |
| 3_139 | 3_198 |
| 4_22 | 4_89 |
| 4_139 | 4_198 |
| 1_134 | 3_216 |
| 2_134 | 4_216 |
| 1_222 | 2_222 |
| 1_223 | 2_223 |
| 1_226 | 2_226 |
| 1_229 | 2_229 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_73 |
| N | 1_296 |
| N | 2_73 |
| N | 2_296 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Did not show prominent activity on PFS in a phase Ib/II trial for patients with hormone receptor-positive breast cancer.
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|